24 Apr 2012
- Published Date
LETTER TO THE EDITOR
“The FDA reports that 14 American women have died during RU 486 abortions and there were over 2,200 adverse incidents for women through use of this drug.”
People do not understand RU486 Abortions they mistakenly believe that women who have chemical abortions pop a pill and, magically, they are no longer pregnant. The FDA protocol for use of this two-drug regime is three to four visits to a doctor with close supervision, said Cheryl Ciamarra, Alabama Citizens for Life Legislative Director. “With the advent of web cam abortions, now taking place at Planned Parenthood clinics in several states, instead of this close supervision, women discuss their abortion over a web cam without a physical exam by a doctor.”
Interesting the manufacturer of RU486 is Russell Ulcloft the same manufacturer of the chemical used by the Nazi's in the gas chambers during the Holocaust.
The fact that Alabama does NOT even have Hospital Admitting privliges as a minimum requirement for aboritonists makes it even more dangerous should this come to Alabama. Alabama can pass a ban on this substandard procedure this session to protect women by passing SB96.
Alabama should also pass HB223 to require not just one doctor with hospital admitting privleges "contract in the drawer", but every abortion provider to have local hospital admitting privliges for the follow up needed from botched abortions.
Current Alabama Vital Statistics do not collect data on the number of chemical verse surgical abortions, however by 2013 that data will begin to be collected due to passage of legislation last year improving reporting of abortion related statistics.
Newer news items:
Older news items:
- Midwife Outraged Over Amendments - 19/04/2012 13:22
- Alabama Can Save Lives by Banning Unsafe "Skype Abortions" - 19/04/2012 10:49
- We should look at how midwives are underutilized - 18/04/2012 10:20
- Reader Speaks Out on Charter Schools - 16/04/2012 13:29
- Alabama needs to “opt out” of Abortion funding mandated by “OBAMACARE” - 22/03/2012 09:35